TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependenceGongwei Wu, Myles Brown, Noriaki Yoshida et al.|Science Translational Medicine|2023Cited by 13
Targeted genomic analysis of cutaneous T cell lymphomas identifies a subset with aggressive clinicopathological featuresKimon V. Argyropoulos, M. Lia Palomba, Franck Rapaport et al.|Blood Cancer Journal|2020Cited by 12
Dual-Targeted Therapy with Ruxolitinib Plus Duvelisib for T-Cell LymphomaAlison J. Moskowitz, Sarah McCue Horwitz, Nivetha Ganesan et al.|Blood|2024Cited by 10
High-Depth, Targeted, Next Generation Sequencing Identifies Novel Genetic Alterations in Cutaneous T-Cell LymphomaKimon V. Argyropoulos, Lia Palomba, Sarah McCue Horwitz et al.|Blood|2015Cited by 1
Immune Signature of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin As Second-Line Therapy for Relapsed or Refractory Classical Hodgkin LymphomaBeatriz Wills, Alison J. Moskowitz, Nivetha Ganesan et al.|Blood|2022Cited by 0